Abstract
C-X-C chemokine receptor type 4 (CXCR4) constitutes a promising target for tumor diagnosis and therapy. Herein, we evaluate a new 1,4,7,10-tetraazacyc......
小提示:本篇文献需要登录阅读全文,点击跳转登录